• 2012

Company Description

ILiAD is a clinical stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.

ILiAD Biotechnologies, LLC (ILiAD) is a clinical stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis. ILiAD's lead candidate is BPZE1, a live-attenuated pertussis vaccine that has successfully completed a Phase 1 human clinical trial.